AnnouncedFiled 28 April 2026
Converge Bio Inc. raised $25M
Converge Bio Inc., a biotech company based in Claymont, DE, raised $25M in a new equity round, according to a filing dated 28 April 2026.
Announced on 13 January 2026, 105 days before the filing. techcrunch.com ↗
- Filed
- 28 April 2026
- Round
- Equity round
- Amount sold
- $25M
- Offering size
- $25M
- Investors so far
- 19
- Based in
- Claymont, DE
- Website
- converge-bio.com
Investors on the board
Firms come from the venture funds whose filings name a director of this company.
Who is on the board
1 director of this company is named on venture funds' filings. Sign in free with Google to see who, the full filing, and a short list of rounds like this each morning.
Sign in with GoogleHow it compares
Larger than 75% of the 854 tracked raises with an amount filed in 2026, and than 54% of the 79 in biotech.
Converge Bio Inc. in public filings
| Filed | Filing | Sold | Raise |
|---|---|---|---|
| 28 Apr 2026 | New filing | $25M | This raise |
More with TLV on the board
- Next Insurance, Inc.$225M
- Guesty, Inc.$19.8M
- Buildup Technologies Inc.$5.74M
Other unannounced rounds
- Thoughtform, Inc.$6.6M
- ProvenAir Technologies, Inc.$488K
- Gravitics, Inc.$17M
- SurgiBox Inc.$486K
- Voxel Labs Inc.$10M
- DVx Atomic Co.$18.5M
Seen it announced?
Send the link and the check will look at it.